Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 125    |    Report Code: BMIRE00028239    |    Category: Life Sciences

Europe Platelet Rich Plasma Tube Market

欧洲富血小板血浆管市场预计将从2022年的2.2852亿美元增长到2028年的5.7584亿美元。预计2022年至2028年复合年增长率为16.7% .

 

运动损伤病例的增加推动欧洲富血小板血浆管市场的增长

 

参与体育活动的激增会导致相关的运动损伤。 PRP 注射可以帮助刺激接受微创手术的受伤运动员的康复。 PRP 治疗是通过收集患者的血液,然后通过离心过程将血浆与血细胞分离来进行的。将分离出的血浆注入受伤部位。注射中收获的血浆浓度较高,其中含有生长因子,可刺激伤口更快愈合和恢复。 PRP 注射在治疗肌腱、肌肉和韧带损伤方面已变得很流行。根据国家医学图书馆2021年发布的一份报告,近年来足球运动员的受伤率有所上升。运动相关损伤的高发生率通常归因于运动专业化和幼年时期的高强度练习。 Statista研究部2022年发布的报告显示,2020年法国滑雪者受伤最频繁。滑雪者的下肢受伤风险较高,超过50%的受伤发生在腿部和膝盖2019-2020年期间。因此,运动损伤发生率的上升引发了运动员对PRP治疗的需求,从而推动了欧洲富血小板血浆(PRP)管市场的增长。

 

欧洲富血小板血浆管市场概况

 

德国在美容医学领域名列前茅的国家。根据国际美容整形外科协会 (ISAPS) 的统计,它在全球执行大量美容手术方面排名第四。 2018年,全国进行的美容手术总数为922,056例,约占全球手术总数的4.0%。此外,人口老龄化的增加可能会导致美容手术的数量增加,因为皮肤松弛在这一人群中最为常见。根据 aarpinternational.org,德国是五个“超级老龄化”国家之一。世界各地的社会。到2050年,三分之一的人口将年龄在65岁或以上。因此,德国进行美容手术的案例不断增加,增加了对富含血小板血浆管的需求。

 

欧洲富血小板血浆管市场收入及预测至 2028 年(百万美元)

欧洲富血小板血浆管市场细分

 

欧洲富血小板血浆管市场根据用途、数量进行细分、最终用户和国家/地区。

 

根据使用情况,欧洲富血小板血浆管市场分为皮肤再生、头发修复、骨科、肿瘤外科、妇科等。 2022年,其他细分市场占据最大的市场份额。嫩肤细分领域进一步细分为疤痕、皮肤老化、痤疮、皮肤溃疡等。

 

按体积计算,欧洲血小板丰富的血浆管市场细分为5毫升以下、6毫升至10毫升、10毫升以上。 2022年,10ml以上细分市场占据最大市场份额。

 

欧洲富血小板血浆管市场,按最终用户分为 MedSpa、皮肤科办公室、医院和医疗保健实践、三科医生实践等。 2022年,医院和医疗保健实践领域占据最大的市场份额。

 

根据国家/地区,欧洲富血小板血浆管市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。 2022年,欧洲其他地区在欧洲富血小板血浆管市场占据最大份额。

 

ADVIN HEALTH CARE;生物X;恒硕医疗(杭州)有限公司;林根精密医疗制品有限公司;和 Manso Medical Co Ltd 是欧洲富血小板血浆管市场的领先公司。



Europe Platelet Rich Plasma Tube Strategic Insights

Strategic insights for Europe Platelet Rich Plasma Tube involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-platelet-rich-plasma-tube-market-strategic-framework.webp
Get more information on this report

Europe Platelet Rich Plasma Tube Report Scope

Report Attribute Details
Market size in 2022 US$ 228.52 Million
Market Size by 2028 US$ 575.84 Million
Global CAGR (2022 - 2028) 16.7%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 用途
  • 皮肤嫩肤
  • 头发修复
  • 骨科
  • 肿瘤外科
  • 妇科
By 容量
  • 少于 5 毫升
  • 6 毫升至 10 毫升
  • 超过 10 毫升
By 最终用户
  • MedSpas
  • 皮肤科诊所
  • 医院和医疗机构
  • 毛发科医生
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • ADVIN HEALTH CARE
  • BIO-X
  • Henso Medical (Hangzhou) Co Ltd
  • Lingen Precision Medical Products Co Ltd
  • Manso Medical Co Ltd
  • Get more information on this report

    Europe Platelet Rich Plasma Tube Regional Insights

    The regional scope of Europe Platelet Rich Plasma Tube refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-platelet-rich-plasma-tube-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Platelet Rich Plasma Tube Market

    1. ADVIN HEALTH CARE
    2. BIO-X
    3. Henso Medical (Hangzhou) Co Ltd
    4. Lingen Precision Medical Products Co Ltd
    5. Manso Medical Co Ltd
    Frequently Asked Questions
    How big is the Europe Platelet Rich Plasma Tube Market?

    The Europe Platelet Rich Plasma Tube Market is valued at US$ 228.52 Million in 2022, it is projected to reach US$ 575.84 Million by 2028.

    What is the CAGR for Europe Platelet Rich Plasma Tube Market by (2022 - 2028)?

    As per our report Europe Platelet Rich Plasma Tube Market, the market size is valued at US$ 228.52 Million in 2022, projecting it to reach US$ 575.84 Million by 2028. This translates to a CAGR of approximately 16.7% during the forecast period.

    What segments are covered in this report?

    The Europe Platelet Rich Plasma Tube Market report typically cover these key segments-

  • 用途 (皮肤嫩肤, 头发修复, 骨科, 肿瘤外科, 妇科)
  • 容量 (少于 5 毫升, 6 毫升至 10 毫升, 超过 10 毫升)
  • 最终用户 (MedSpas, 皮肤科诊所, 医院和医疗机构, 毛发科医生)
  • What is the historic period, base year, and forecast period taken for Europe Platelet Rich Plasma Tube Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Platelet Rich Plasma Tube Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Europe Platelet Rich Plasma Tube Market?

    The Europe Platelet Rich Plasma Tube Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • ADVIN HEALTH CARE
  • BIO-X
  • Henso Medical (Hangzhou) Co Ltd
  • Lingen Precision Medical Products Co Ltd
  • Manso Medical Co Ltd
  • Who should buy this report?

    The Europe Platelet Rich Plasma Tube Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Platelet Rich Plasma Tube Market value chain can benefit from the information contained in a comprehensive market report.